Yokkaichi, Japan

Kazuhiro Kawada

This inventor holds 2 USPTO granted patents. Top assignee: Ajinomoto Co., Ltd.. Active years: 1987-1988.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 1987-1988

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kazuhiro Kawada: Innovator in Medicinal Chemistry

Introduction

Kazuhiro Kawada is a notable inventor based in Yokkaichi, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his work on phenylalanine derivatives. With a total of 2 patents, Kawada's innovations are aimed at enhancing the absorption of important medicaments.

Latest Patents

Kawada's latest patents focus on phenylalanine derivatives and their applications. The first patent describes a phenylalanine derivative with a specific structural formula, which is useful for promoting the absorption of medicaments such as insulin. This innovation has the potential to improve the efficacy of treatments for individuals requiring insulin therapy. The second patent reiterates the same focus on phenylalanine derivatives, emphasizing their role in enhancing drug absorption.

Career Highlights

Kawada is associated with Ajinomoto Co., Ltd., a leading company in the field of food and biotechnology. His work at Ajinomoto has allowed him to explore various applications of his inventions, contributing to advancements in medicinal chemistry.

Collaborations

Kawada has collaborated with notable coworkers, including Koji Toi and Koji Fukushima. These partnerships have likely enriched his research and development efforts, fostering innovation in his field.

Conclusion

Kazuhiro Kawada's contributions to medicinal chemistry through his patents on phenylalanine derivatives highlight his role as an innovator. His work continues to pave the way for advancements in drug absorption technologies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…